FDA approves Verzenio as the first and only CDK4/6 inhibitor for certain people with HR+HER2- high-risk early breast cancer Read more
US FDA grants breakthrough therapy designation to Roche’s anti-amyloid beta antibody gantenerumab Read more
Zydus Cadila receives tentative approval from US FDA for Adapalene and Benzoyl Peroxide Gel Read more